What is the best use of serum tumor markers?

What is the best use of serum tumor markers?

• A. Screening for cancer
• B. Initial diagnosis of cancer
• C. Monitoring patients undergoing cancer treatment
• D. Determining patient prognosis

Answer: (C)

Serial measurement of serum tumor markers is most informative for watching how a cancer responds to therapy and for spotting relapse over time. By tracking marker levels at multiple points, clinicians can see whether the tumor burden is shrinking with treatment, remaining stable, or increasing, which helps decide whether to continue, change, or stop a therapy. A falling marker during treatment often correlates with a favorable response, while rising levels can indicate progression or recurrence even before symptoms or new imaging findings appear. This dynamic approach is what makes tumor markers especially valuable in the management phase of cancer care. They aren’t suitable for screening in healthy people because they aren’t sensitive or specific enough, leading to false positives and unnecessary interventions. They aren’t reliable on their own for a new cancer diagnosis, since biopsy and imaging are needed to confirm cancer. Some markers may have prognostic relevance in certain cancers, but they’re not used alone to determine prognosis; they’re interpreted alongside imaging and clinical data.

Serial measurement of serum tumor markers is most informative for watching how a cancer responds to therapy and for spotting relapse over time. By tracking marker levels at multiple points, clinicians can see whether the tumor burden is shrinking with treatment, remaining stable, or increasing, which helps decide whether to continue, change, or stop a therapy. A falling marker during treatment often correlates with a favorable response, while rising levels can indicate progression or recurrence even before symptoms or new imaging findings appear. This dynamic approach is what makes tumor markers especially valuable in the management phase of cancer care.

They aren’t suitable for screening in healthy people because they aren’t sensitive or specific enough, leading to false positives and unnecessary interventions. They aren’t reliable on their own for a new cancer diagnosis, since biopsy and imaging are needed to confirm cancer. Some markers may have prognostic relevance in certain cancers, but they’re not used alone to determine prognosis; they’re interpreted alongside imaging and clinical data.